Alvotech Starts Confirmatory Study for Biosimilar Candidate to Entyvio
Hutchmed's Partner Takeda Pharmaceutical Gets Go-Ahead to Produce, Market Colorectal Cancer Drug in Japan
Takeda's FRUZAQLA Capsules Approved in Japan for Advanced Colorectal Cancer Treatment
Express News | Takeda Pharmaceutical: Japan has approved FRUZAQLA (FRUQUINTINIB) for the treatment of unresectable advanced or recurrent colorectal cancer.
Sanofi Sarclisa Combo Gains Approval as First-line Multiple Myeloma Treatment
Wave Life Sciences Gains as B. Riley Issues Buy on RNS Editing Tech